AIMS: Chronic granulomatous disease (CGD) is a primary immunodeficiency caused by mutations in the phagocyte reactive oxygen species (ROS)-producing NOX2 enzyme complex and characterized by recurrent infections associated with hyperinflammatory and autoimmune manifestations. A translational, comparative analysis of CGD patients and the corresponding ROS-deficient Ncf1(m1J) mutated mouse model was performed to reveal the molecular pathways operating in NOX2 complex deficient inflammation. RESULTS: A prominent type I interferon (IFN) response signature that was accompanied by elevated autoantibody levels was identified in both mice and humans lacking functional NOX2 complex. To further underline the systemic lupus erythematosus (SLE)-related autoimmune process, we show that naïve Ncf1(m1J) mutated mice, similar to SLE patients, suffer from inflammatory kidney disease with IgG and C3 deposits in the glomeruli. Expression analysis of germ-free Ncf1(m1J) mutated mice reproduced the type I IFN signature, enabling us to conclude that the upregulated signaling pathway is of endogenous origin. INNOVATION: Our findings link the previously unexplained connection between ROS deficiency and increased susceptibility to autoimmunity by the discovery that activation of IFN signaling is a major pathway downstream of a deficient NOX2 complex in both mice and humans. CONCLUSION: We conclude that the lack of phagocyte-derived oxidative burst is associated with spontaneous autoimmunity and linked with type I IFN signature in both mice and humans.
AIMS: Chronic granulomatous disease (CGD) is a primary immunodeficiency caused by mutations in the phagocyte reactive oxygen species (ROS)-producing NOX2 enzyme complex and characterized by recurrent infections associated with hyperinflammatory and autoimmune manifestations. A translational, comparative analysis of CGD patients and the corresponding ROS-deficient Ncf1(m1J) mutated mouse model was performed to reveal the molecular pathways operating in NOX2 complex deficient inflammation. RESULTS: A prominent type I interferon (IFN) response signature that was accompanied by elevated autoantibody levels was identified in both mice and humans lacking functional NOX2 complex. To further underline the systemic lupus erythematosus (SLE)-related autoimmune process, we show that naïve Ncf1(m1J) mutated mice, similar to SLE patients, suffer from inflammatory kidney disease with IgG and C3 deposits in the glomeruli. Expression analysis of germ-free Ncf1(m1J) mutated mice reproduced the type I IFN signature, enabling us to conclude that the upregulated signaling pathway is of endogenous origin. INNOVATION: Our findings link the previously unexplained connection between ROS deficiency and increased susceptibility to autoimmunity by the discovery that activation of IFN signaling is a major pathway downstream of a deficient NOX2 complex in both mice and humans. CONCLUSION: We conclude that the lack of phagocyte-derived oxidative burst is associated with spontaneous autoimmunity and linked with type I IFN signature in both mice and humans.
Authors: Roberto Rangel; Morgan R McKeller; Jennifer C Sims-Mourtada; Cristina Kashi; Kelly Cain; Eric D Wieder; Jeffrey J Molldrem; Lan V Pham; Richard J Ford; Patricia Yotnda; Christiane Guret; Véronique Francés; Hector Martinez-Valdez Journal: J Biol Chem Date: 2005-03-09 Impact factor: 5.157
Authors: Micah T McClain; Latisha D Heinlen; Gregory J Dennis; Jon Roebuck; John B Harley; Judith A James Journal: Nat Med Date: 2004-12-26 Impact factor: 53.440
Authors: U Dianzani; A Funaro; D DiFranco; G Garbarino; M Bragardo; V Redoglia; D Buonfiglio; L B De Monte; A Pileri; F Malavasi Journal: J Immunol Date: 1994-08-01 Impact factor: 5.422
Authors: Jack J Bleesing; Margarida M Souto-Carneiro; William J Savage; Margaret R Brown; Cynthia Martinez; Sule Yavuz; Sebastian Brenner; Richard M Siegel; Mitchell E Horwitz; Peter E Lipsky; Harry L Malech; Thomas A Fleisher Journal: J Immunol Date: 2006-06-01 Impact factor: 5.422
Authors: F Sellebjerg; M Krakauer; D Hesse; L P Ryder; I Alsing; P E H Jensen; N Koch-Henriksen; A Svejgaard; P Soelberg Sørensen Journal: Eur J Neurol Date: 2009-06-22 Impact factor: 6.089
Authors: Aleixo M Muise; Wei Xu; Cong-Hui Guo; Thomas D Walters; Victorien M Wolters; Ramzi Fattouh; Grace Y Lam; Pingzhao Hu; Ryan Murchie; Mary Sherlock; Juan Cristóbal Gana; Richard K Russell; Michael Glogauer; Richard H Duerr; Judy H Cho; Charlie W Lees; Jack Satsangi; David C Wilson; Andrew D Paterson; Anne M Griffiths; Mark S Silverberg; John H Brumell Journal: Gut Date: 2011-09-07 Impact factor: 23.059
Authors: Dan Li; Bharati Matta; Su Song; Victoria Nelson; Kirsten Diggins; Kim R Simpfendorfer; Peter K Gregersen; Peter Linsley; Betsy J Barnes Journal: JCI Insight Date: 2020-01-30
Authors: Deborah Kienhöfer; Jonas Hahn; Julia Stoof; Janka Zsófia Csepregi; Christiane Reinwald; Vilma Urbonaviciute; Caroline Johnsson; Christian Maueröder; Malgorzata J Podolska; Mona H Biermann; Moritz Leppkes; Thomas Harrer; Malin Hultqvist; Peter Olofsson; Luis E Munoz; Attila Mocsai; Martin Herrmann; Georg Schett; Rikard Holmdahl; Markus H Hoffmann Journal: JCI Insight Date: 2017-05-18
Authors: Jorge David Rojas Márquez; Taoyingnan Li; Adam R R McCluggage; Joel M J Tan; Aleixo Muise; Darren E Higgins; John H Brumell Journal: J Immunol Date: 2020-12-07 Impact factor: 5.422